Inhibikase Therapeutics, Inc. (IKT) Earnings
NASDAQ·Healthcare·Biotechnology
$1.55
+1.97%
Mkt Cap $238.61M
EPS — Estimate vs Actual
Mkt Cap
$238.61M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54
NASDAQ·Healthcare·Biotechnology
$1.55
+1.97%
Mkt Cap $238.61M
Mkt Cap
$238.61M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54